Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giancarlo Icardi

Showing results (1-10 of 229) with videos related to

Pageof 23
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2008
Simultaneous detection of anti-HCV antibody and HCV core antigenFilippo Ansaldi, Giancarlo Icardi
Expert Opinion on Biological Therapy|February 9, 2011
Intradermal influenza vaccine and new devices: a promising chance for vaccine improvementFilippo Ansaldi, Paolo Durando, Giancarlo Icardi
Expert Opinion on Biological Therapy|March 12, 2010
MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at riskPaolo Durando, Giancarlo Icardi, Filippo Ansaldi
Human Vaccines & Immunotherapeutics|February 2, 2012
Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection systemGiancarlo Icardi, Andrea Orsi, Antonella Ceravolo, et al.
World Journal of Gastroenterology|January 13, 2016
Overview of hepatitis B virus mutations and their implications in the management of infectionPatrizia Caligiuri, Rita Cerruti, Giancarlo Icardi, et al.
Expert Review of Molecular Diagnostics|October 4, 2024
Multiplex molecular assays for the laboratory-based and point-of-care diagnosis of infections caused by seasonal influenza, COVID-19, and RSVAlexander Domnich, Elvira Massaro, Giancarlo Icardi, et al.
Expert Review of Vaccines|December 14, 2011
Fluzone(®) Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adultsFilippo Ansaldi, Daniela de Florentiis, Paolo Durando, et al.
Human Vaccines & Immunotherapeutics|December 29, 2021
An exploratory study to assess patterns of influenza- and pneumonia-related mortality among the Italian elderlyElettra Fallani, Andrea Orsi, Alessio Signori, et al.
International Journal of Molecular Sciences|July 19, 2016
Pneumococcus and the Elderly in Italy: A Summary of Available Evidence Regarding Carriage, Clinical Burden of Lower Respiratory Tract Infections and On-Field Effectiveness of PCV13 VaccinationAndrea Orsi, Filippo Ansaldi, Cecilia Trucchi, et al.
World Journal of Gastroenterology|August 12, 2014
Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapyFilippo Ansaldi, Andrea Orsi, Laura Sticchi, et al.
Pageof 23

Showing results (1-10 of 229) with videos related to

Sort By:
Pageof 23
Methods in Molecular Biology (Clifton, N.J.)|November 15, 2008
Simultaneous detection of anti-HCV antibody and HCV core antigenFilippo Ansaldi, Giancarlo Icardi
Expert Opinion on Biological Therapy|February 9, 2011
Intradermal influenza vaccine and new devices: a promising chance for vaccine improvementFilippo Ansaldi, Paolo Durando, Giancarlo Icardi
Expert Opinion on Biological Therapy|March 12, 2010
MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at riskPaolo Durando, Giancarlo Icardi, Filippo Ansaldi
Human Vaccines & Immunotherapeutics|February 2, 2012
Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection systemGiancarlo Icardi, Andrea Orsi, Antonella Ceravolo, et al.
World Journal of Gastroenterology|January 13, 2016
Overview of hepatitis B virus mutations and their implications in the management of infectionPatrizia Caligiuri, Rita Cerruti, Giancarlo Icardi, et al.
Expert Review of Molecular Diagnostics|October 4, 2024
Multiplex molecular assays for the laboratory-based and point-of-care diagnosis of infections caused by seasonal influenza, COVID-19, and RSVAlexander Domnich, Elvira Massaro, Giancarlo Icardi, et al.
Expert Review of Vaccines|December 14, 2011
Fluzone(®) Intradermal vaccine: a promising new chance to increase the acceptability of influenza vaccination in adultsFilippo Ansaldi, Daniela de Florentiis, Paolo Durando, et al.
Human Vaccines & Immunotherapeutics|December 29, 2021
An exploratory study to assess patterns of influenza- and pneumonia-related mortality among the Italian elderlyElettra Fallani, Andrea Orsi, Alessio Signori, et al.
International Journal of Molecular Sciences|July 19, 2016
Pneumococcus and the Elderly in Italy: A Summary of Available Evidence Regarding Carriage, Clinical Burden of Lower Respiratory Tract Infections and On-Field Effectiveness of PCV13 VaccinationAndrea Orsi, Filippo Ansaldi, Cecilia Trucchi, et al.
World Journal of Gastroenterology|August 12, 2014
Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapyFilippo Ansaldi, Andrea Orsi, Laura Sticchi, et al.
Pageof 23